Skip to main content
. 2023 May 19;39(3):250–302. doi: 10.1002/joa3.12851
Abstract 2
Table of Contents 2
Take‐Home Messages 4
Section 1 Introduction 4
1.1 Preamble 4
1.2 Document scope and rationale 4
1.3 Editorial independence 5
1.4 Organization of the writing committee 5
1.5 Evidence review and formulation of recommendation 5
1.6 Class of recommendation and level of evidence 6
1.7 Document review and approval 6
1.8 Document updates 7
1.9 Relevant clinical practice 7
Section 2 General concepts 7
2.1 Definitions 7
2.2 Remote monitoring considerations 8
Synopsis 8
Recommendation‐specific supportive text 9
2.3 Remote monitoring payment/reimbursement models 9
Synopsis 9
Recommendation‐specific supportive text 10
Section 3 Administrative and nonclinical staff 10
3.1 Patient enrollment techniques 10
Synopsis 10
Recommendation‐specific supportive text 10
3.2 Managing and updating manufacturer websites 11
Synopsis 11
Recommendation‐specific supportive text 11
3.3 Techniques to optimize patient connectivity 11
Synopsis 11
Recommendation‐specific supportive text 11
Section 4 Staffing of remote monitoring clinics 11
4.1 Recommended staffing requirements for remote monitoring 12
Synopsis 12
4.2 Staff credentialing and qualifications for remote monitoring 15
Synopsis 15
Recommendation‐specific supportive text 15
Section 5 Technical considerations in remote monitoring 15
5.1 Devices with noncontinuous remote monitoring 16
Synopsis 16
Recommendation‐specific supportive text 16
5.2 Site‐based remote monitoring 16
Synopsis 16
Recommendation‐specific supportive text 18
Section 6 Alert‐based remote monitoring 18
Synopsis 19
Recommendation‐specific supportive text 19
Section 7 Programming considerations for optimal remote monitoring 19
7.1 Manufacturer and device‐specific knowledge 20
Synopsis 20
Recommendation‐specific supportive text 20
7.2 Programming for clinical indications with different types of cardiovascular implantable electronic devices 20
Synopsis 21
Recommendation‐specific supportive text 21
7.3 Special programming considerations for implantable loop recorders 23
Synopsis 23
Recommendation‐specific supportive text 24
Section 8 Managing alerts 25
8.1 Defining high‐priority alerts 25
Synopsis 25
Recommendation‐specific supportive text 25
8.2 Programming considerations to minimize inappropriate alerts 27
Synopsis 27
Recommendation‐specific supportive text 27
8.3 Timeline recommendations for alert management 27
Synopsis 27
Recommendation‐specific supportive text 27
Section 9 Remote monitoring reporting 28
9.1 Communication of the remote monitoring report to patients 28
Synopsis 29
Recommendation‐specific supportive text 29
9.2 Components of a comprehensive report 29
9.3 Techniques for incorporating reports into electronic health records 29
Synopsis 29
Recommendation‐specific supportive text 29
Section 10 Patient education for remote monitoring 31
10.1 Patient education for participation and compliance 31
Synopsis 31
Recommendation‐specific supportive text 32
10.2 Patient education of clinic‐specific policies 33
Synopsis 33
Recommendation‐specific supportive text 33
Section 11 Manufacturer responsibilities with remote monitoring 33
11.1 Manufacturers’ role to optimize individual patient care 33
Synopsis 34
Recommendation‐specific supportive text 34
11.2 Manufacturers’ role in the management of patient safety advisories via remote monitoring 34
Synopsis 35
Recommendation‐specific supportive text 35
11.3 Support surrounding implantation from manufacturers 35
Synopsis 35
Recommendation‐specific supportive text 36
Section 12 Third‐party resources for remote monitoring 36
12.1 Use of third‐party resources in remote monitoring 36
Synopsis 36
Recommendation‐specific supportive text 37
Section 13 Pediatric considerations with remote monitoring 37
Section 14 Geographic differences with remote monitoring practices 38
14.1 Availability of remote monitoring 38
Synopsis 38
Recommendation‐specific supportive text 38
Section 15 Knowledge gaps and future needs 38
15.1 Remote monitoring can “shorten” large geographic distances 38
15.2 Remote programming 38
15.3 Inequitable access to cardiovascular implantable electronic device remote monitoring 39
15.4 Reimbursement reform for remote monitoring 39
15.5 Better information, not more information 39
15.6 Direct patient access to device information 40
15.7 Summary: Further research about remote monitoring 40
15.8 Summary: Past, present, and future 40
References 40
Appendix 48